Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors

Clinical trial NCT05338580 · WITHDRAWN

Trial details

NCT number: NCT05338580
Sponsor: TJ Biopharma Co., Ltd.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

First-line Non-small-cell Lung Cancer First-line Urothelial Carcinoma Second-line Urothelial Carcinoma Second-line Melanoma

Start date: 2023-12-31
Primary completion: 2023-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.